FDA Clearance Tracker · P150011
PERCEVAL SUTURELESS HEART VALVE
Last checked: Nov 19, 2026Latest source record: Jan 8, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jan 8, 2016
Approved
Time to decision
312 days
Received Mar 2, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150011
- Device name
- PERCEVAL SUTURELESS HEART VALVE
- Applicant
- Corcym S.r.l.
- Applicant location
- Saluggia
- Received
- Mar 2, 2015
- Decided
- Jan 8, 2016
- Decision
- Approved
- Supplements
- 34 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Perceval Sutureless Heart Valve. This device is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LWR. The earliest in FDA's data is P790007, decided Nov 15, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Corcym S.r.l.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261707 · Decided Jun 18, 2026 · 27 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
K260498 · Decided Apr 14, 2026 · 60 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
K230318 · Decided Apr 7, 2023 · 60 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.